Depression Remission at Twelve Months

The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event date.

Date Reviewed: September 28, 2022

Measure Info

MIPS 370 CMIT ID 190
Measure Type
Patient Reported Outcome
Measure Steward
Minnesota Community Measurement
Clinical Topic Area

Care Setting
Data Source
Electronic Health Records

Measuring patient response to major depressive disorder (MDD) is incredibly important as they progress toward remission. The primary goal is to achieve remission or to get the patient to be predominately symptom-free when considering treatment options. The 12-month time frame is not based on clinical evidence but is more feasible to measure MDD remission than a 6-month time frame. The PHQ-9 score of five is evidence-based but the value of putting a patient on medication to achieve remission if their PHQ-9 is six is unclear. There are other evidence-based standardized tools to measure MDD in addition to the PHQ-9. The collection burden for this performance measure is moderate and physician control is low.